News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
598,499 Results
Type
Article (44266)
Company Profile (91)
Press Release (554132)
Multimedia
Podcasts (92)
Webinars (20)
Section
Business (159386)
Career Advice (2503)
Deals (28946)
Drug Delivery (125)
Drug Development (76768)
Employer Resources (142)
FDA (14515)
Job Trends (12753)
News (284807)
Policy (28178)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (1)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (2689)
Academic (1)
Accelerated approval (46)
Adcomms (33)
Allergies (172)
Alliances (40455)
ALS (213)
Alzheimer's disease (1836)
Antibody-drug conjugate (ADC) (451)
Approvals (14849)
Artificial intelligence (643)
Autoimmune disease (284)
Automation (51)
Bankruptcy (317)
Best Places to Work (10283)
BIOSECURE Act (17)
Biosimilars (205)
Biotechnology (67)
Bladder cancer (196)
Brain cancer (72)
Breast cancer (739)
Cancer (5753)
Cardiovascular disease (490)
Career advice (2132)
Career pathing (42)
CAR-T (324)
CDC (59)
Celiac Disease (1)
Cell therapy (881)
Cervical cancer (41)
Clinical research (67093)
Collaboration (1851)
Company closure (6)
Compensation (762)
Complete response letters (88)
COVID-19 (2707)
CRISPR (107)
C-suite (1172)
Cystic fibrosis (137)
Data (7836)
Decentralized trials (3)
Denatured (16)
Depression (178)
Dermatology (82)
Diabetes (574)
Diagnostics (6392)
Digital health (45)
Diversity (8)
Diversity, equity & inclusion (39)
Drug discovery (293)
Drug pricing (188)
Drug shortages (28)
Duchenne muscular dystrophy (290)
Earnings (62642)
Editorial (66)
Employer branding (19)
Employer resources (134)
Events (84429)
Executive appointments (1089)
FDA (18070)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (17)
Frontotemporal dementia (33)
Funding (1566)
Gene editing (232)
Generative AI (59)
Gene therapy (743)
GLP-1 (1075)
Government (4602)
Grass and pollen (7)
Guidances (407)
Healthcare (16788)
HIV (79)
Huntington's disease (59)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (99)
Immunology and inflammation (319)
Immuno-oncology (94)
Indications (186)
Infectious disease (3052)
Inflammatory bowel disease (214)
Inflation Reduction Act (13)
Influenza (135)
Intellectual property (274)
Interviews (535)
IPO (13110)
IRA (49)
Job creations (2757)
Job search strategy (1713)
JPM (57)
Kidney cancer (22)
Labor market (72)
Layoffs (555)
Leadership (46)
Legal (5971)
Liver cancer (105)
Longevity (25)
Lung cancer (782)
Lymphoma (422)
Machine learning (53)
Management (51)
Manufacturing (920)
MASH (210)
Medical device (11556)
Medtech (11659)
Mergers & acquisitions (16957)
Metabolic disorders (1513)
mRNA (205)
Multiple sclerosis (190)
NASH (24)
Neurodegenerative disease (434)
Neuropsychiatric disorders (113)
Neuroscience (3375)
Neurotech (1)
NextGen: Class of 2026 (5795)
Non-profit (4210)
Now hiring (66)
Obesity (703)
Opinion (302)
Ovarian cancer (225)
Pain (258)
Pancreatic cancer (301)
Parkinson's disease (358)
Partnered (30)
Patents (567)
Patient recruitment (668)
Peanut (59)
People (54361)
Pharmaceutical (18)
Pharmacy benefit managers (20)
Phase 1 (20437)
Phase 2 (29540)
Phase 3 (22673)
Pipeline (8600)
Policy (317)
Postmarket research (2395)
Preclinical (8456)
Press Release (60)
Prostate cancer (298)
Psychedelics (63)
Radiopharmaceuticals (293)
Rare diseases (1102)
Real estate (4488)
Recruiting (60)
Regulatory (22865)
Reports (33)
Research institute (2334)
Resumes & cover letters (366)
Rett syndrome (40)
RNA editing (23)
RSV (83)
Schizophrenia (184)
Series A (264)
Series B (192)
Service/supplier (4)
Sickle cell disease (118)
Special edition (22)
Spinal muscular atrophy (171)
Sponsored (44)
Startups (2994)
State (2)
Stomach cancer (20)
Supply chain (111)
Tariffs (80)
The Weekly (74)
Vaccines (1081)
Venture capital (105)
Weight loss (470)
Women's health (106)
Worklife (20)
Date
Last 7 days (618)
Last 30 days (3045)
Last 365 days (27094)
2026 (11736)
2025 (27259)
2024 (31480)
2023 (35240)
2022 (45853)
2021 (49265)
2020 (47875)
2019 (41225)
2018 (31420)
2017 (28292)
2016 (26997)
2015 (31535)
2014 (23727)
2013 (19385)
2012 (20621)
2011 (21641)
2010 (19219)
Location
Africa (769)
Alabama (84)
Alaska (4)
Arizona (253)
Arkansas (14)
Asia (37159)
Australia (7463)
California (11251)
Canada (3488)
China (1310)
Colorado (477)
Connecticut (473)
Delaware (380)
Europe (83217)
Florida (1819)
Georgia (376)
Hawaii (2)
Idaho (55)
Illinois (937)
India (84)
Indiana (529)
Iowa (19)
Japan (507)
Kansas (125)
Kentucky (44)
Louisiana (39)
Maine (64)
Maryland (1449)
Massachusetts (7956)
Michigan (323)
Minnesota (601)
Mississippi (6)
Missouri (138)
Montana (26)
Nebraska (25)
Nevada (129)
New Hampshire (85)
New Jersey (3241)
New Mexico (27)
New York (3064)
North Carolina (1406)
North Dakota (8)
Northern California (5612)
Ohio (343)
Oklahoma (13)
Oregon (31)
Pennsylvania (2345)
Puerto Rico (28)
Rhode Island (43)
South America (1044)
South Carolina (80)
South Dakota (2)
Southern California (4516)
Tennessee (181)
Texas (1925)
United States (40657)
Utah (371)
Vermont (1)
Virginia (303)
Washington D.C. (66)
Washington State (961)
West Virginia (4)
Wisconsin (104)
Wyoming (2)
598,499 Results for "immutep formerly known as prima biomed".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immutep Quarterly Activities Report Q3 FY26
April 30, 2026
·
10 min read
Press Releases
Immutep Receives Nasdaq Notice of Bid Price Deficiency
April 30, 2026
·
2 min read
Press Releases
Immutep Announces Abstract Accepted for Presentation at the American Society of Clinical Oncology (ASCO) 2026 Annual Meeting
April 22, 2026
·
2 min read
Press Releases
Immutep Receives FDA Orphan Drug Designation for Eftilagimod Alfa in Soft Tissue Sarcoma
April 15, 2026
·
3 min read
Press Releases
Immutep Reports Progress from Phase I Study of LAG-3 Agonist for Autoimmune Diseases
March 19, 2026
·
4 min read
Press Releases
Immutep Quarterly Activities Report Q2 FY26
January 29, 2026
·
16 min read
Press Releases
Immutep Achieves 50% Enrolment in Global TACTI-004 (KEYNOTE-F91) Phase III Trial in 1L NSCLC
February 8, 2026
·
4 min read
Press Releases
Orchestra BioMed Reports First Quarter 2026 Financial Results and Highlights Recent Business Updates
May 13, 2026
·
14 min read
Press Releases
Orchestra BioMed to Participate in the Jefferies Global Healthcare Conference 2026
May 19, 2026
·
2 min read
Press Releases
Immutep Quarterly Activities Report Q1 FY26
October 30, 2025
·
10 min read
1 of 59,850
Next
